Sleep Disorders Center of Alabama
790 Montclair Road
Birmingham, Alabama 35213
205-599-1020 http://www.sleepalabama.com kvaughn@sleepalabama.com

Use our guide to learn which trials are right for you!

The Sleep Disorders Center of Alabama currently is a freestanding 6-bed center in a medical office building in the eastern section of Birmingham. The center conducts approximately 1700 clinical studies annually, and about 140 new patients are seen each month.

The state-of-the-art sleep suites offer full polysomnograms for sleep disordered breathing and continuous positive airway pressure (CPAP)/bilevel titration; multiple sleep latency testing (MSLT) for excessive daytime somnolence such as narcolepsy or idiopathic hypersomnolence; tests for abnormal behaviors during sleep such as rapid eye movement (REM) behavior disorder.

The Sleep Disorders Center of Alabama has a strong reputation in the state/region due to Dr. G. Vernon Pegram and Dr. Robert Doekel, who have been in sleep medicine for 42 and 29 years, respectively. The center received its sixth 5 year accreditation from the American Academy of Sleep Medicine in 2005.

Our Mission:
The Sleep Disorders Center of Alabama strives to provide our clients with appropriate staff, facilities, equipment and support services in delivering continually improving care in a most efficient and effective manner.

Our research center has extensive experience conducting Phase II-IV trials in the following therapeutic areas:

  • Insomnia
  • Narcolepsy
  • Cataplexy
  • Shift Work Sleep Disorder
  • Restless Leg Syndrome
  • Periodic Limb Movement Syndrome
  • Obstructive Sleep Apnea
  • Chronic Obstructive Pulmonary Disease
  • Fibromyalgia

The Sleep Disorders Center of Alabama has worked with many companies over the past years on numerous clinical trials. Some are as follows:

  • Glaxo-Smith-Kline
  • Vanda Pharmaceuticals
  • Johnson and Johnson Pharmaceutical Research and Development
  • Alza Corporation
  • Pfizer
  • Sanofi-Synthelabo
  • Sanofi-Aventis
  • Sepracor, Inc.
  • Cephalon, Inc.
  • Neurocrine Biosciences, Inc.
  • Orphan Medical, Inc.
  • Takeda Pharmaceuticals North America
  • Merck Pharmaceuticals
  • Wyeth-Ayerst
  • Lorex Pharmaceuticals
  • Department of Defense
  • Abbott Laboratories
  • Merck Foundation
  • Upjohn Pharmaceuticals
  • Hoffman-LaRoche
  • NIH
  • U.S.A.F.
  • Phillip-Respironics

G. Vernon Pegram, Jr., Ph.D., ABSM
Board certified in Sleep Medicine; licensed clinical psychologist

Robert C. Doekel, Jr., M.D., ABSM
Board certified in Sleep Medicine, Internal Medicine, and Pulmonary Medicine

William G. Adams, Jr., M.D.
Board certified in Internal Medicine

Lisa Ann Withrow, M.D.

Sheila Pegram RN, CCRC
Registered nurse and Certified Clinical Research Coordinator
15 years experience coordinating clinical trials

Brett Berry LPN, RPSGT, CCRC
Practical Nurse, Registered sleep technologist, Certified Clinical Research Coordinator
11 years experience in the field of sleep medicine and 6 coordinating clinical trials

Krager Vaughn, RPSGT, CCRC
Registered sleep technologist, Clinical Research Coordinator
10 years experience in the field of sleep medicine and 5 coordinating clinical trials

Wes Booth, RPSGT, CRC
Registered sleep technologist, Clinical Research Coordinator
5 years experience in the field of sleep medicine and 5 coordinating clinical trials

A number of qualified and registered Sleep Technologists and Registered Respiratory Therapist to run overnight studies as well as titrate PAP.


The Sleep Disorders Center of Alabama is a freestanding practice and not affiliated with any hospital or other organization for the purposes of research. The center is not governed by an internal review board and normally utilizes a central IRB for clinical trials.

For patient recruitment, the Sleep Disorders Center of Alabama relies mostly on it's large database of clinical and research patients. Local print advertisement, radio, TV, and direct mail are also used to reach the densely populated Birmingham metro area residents and workforce.


Cardiology/Vascular Diseases
Dental/Maxillofacial Surgery
Gastroenterology
Musculoskeletal
Neurology
Otolaryngology
Psychiatry/Psychology
Pulmonary/Respiratory Diseases

All research studies are performed and retained at our state-of-the-art center located in east Birmingham on Montclair Road. At this location are six PSG or "sleep" rooms capable of acquiring completely digital recordings, which are easily converted to European Data Format for viewing by any central scoring site. The Sleep Disorders Center of Alabama has been designated by SANDMAN SLEEP DIAGNOSTICS as a "center of excellence" and they constantly update our equipment to keep up with today's rapidly advancing technology.

We are located a short 7 miles from the Birmingham International Airport and minutes from a variety of shopping and dining experiences in Birmingham's historical southside district.

The center has all the amenities to comfortably accommodate study monitors as well as patients. All the patient rooms have recently been remodel by a local interior decorator and feature all new bedroom furniture, memory foam mattresses, 32 inch HD LCD Cable TV , and private showers. Study monitors appreciate our quiet and spacious conference room with dedicated phone lines and internet access.


Krager Vaughn, RPSGT, CCRC
Sleep Disorders Center of Alabama
790 Montclair Road, Suite 200
Birmingham, AL 35213
USA
205-599-1020
205-595-1503 (fax)
kvaughn@sleepalabama.com
www.sleepalabama.com


We've found
3 trials
at this facility
Psychiatry / Psychology Clinical Trial
Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Birmingham, AL
Click here to add this to my saved trials
Clinical Trial
Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Birmingham, AL
Click here to add this to my saved trials
Idiopathic Hypersomnia Clinical Trial
A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Birmingham, AL
Click here to add this to my saved trials